(MedPage Today) — CHICAGO — Patients with undetectable disease after induction therapy for newly diagnosed multiple myeloma (NDMM) did not have significantly better outcomes with a stem-cell transplant versus drug therapy, according to a study…
Source link : https://www.medpagetoday.com/meetingcoverage/asco/115894
Author :
Publish date : 2025-06-03 21:41:00
Copyright for syndicated content belongs to the linked Source.